TransEnterix Seeks FDA 510(k) Clearance for SurgiBot System

TransEnterix has submitted FDA 510(k) premarket notification of its SurgiBot system for robotically enhanced laparoscopy, the Morrisville, N.C., devicemaker announced Monday.

The system is the first of its kind, offering instrument dexterity and precision, surgeon comfort and minimal patient incisions, the company says. The device is mobile, which reduces the need for additional clinical professionals, and is cost-effective.

Mimicking laparoscopic surgical procedures, the system uses surgeon-controlled flexible instruments to articulate channels and interact with the patient. Several instruments can be deployed simultaneously through a single incision.

TransEnterix develops robotic devices and flexible instruments for minimally invasive procedures. — Jason Scott